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HIV uses autophagy for its own means
N
ot satisfi  ed with simply thwarting 
its host’s defensive maneuvers, 
HIV actually twists one to its 
advantage,  based on new fi  ndings  from 
Kyei et al. (1). The research suggests that 
autophagy—often used to capture and de-
stroy invaders—aids in protein processing 
steps essential to HIV proliferation.
Autophagy is probably better known 
for its role in stress response pathways, 
particularly during bouts of nutritional 
deprivation.  But in 2004, independent 
publications from the laboratories of Vojo 
Deretic and Tamotsu Yoshimori implicated 
autophagy in mammalian cell-autonomous 
defense mechanisms against pathogens (2, 3). 
Many publications have since revealed that 
a range of intracellular pathogens from bac-
teria to viruses to protozoa are targets for 
autophagosomes, which eventually acidify 
and become lytic bags of bug destruction (4).
Deretic fi   gured the pathogenic tar-
gets didn’t necessarily stop there. “We 
thought that autophagy would be a cool 
device to capture and digest incoming HIV 
virions,” he says. “So, we 
thought if we induced au-
tophagy, maybe it would di-
gest HIV.” In the new work, 
his group shows that the 
opposite occurred—virus 
levels were increased when 
the researchers chemically 
induced autophagocytosis 
in macrophages.
Conversely, blocking 
autophagocytosis lessened 
virus production. Reduced viral levels were 
accompanied by a blockade in the process-
ing of Gag—a key precursor protein for virus 
assembly. The group found that Gag local-
ized to complexes containing an autophagy 
protein, LC3. “It looked paradoxical,” says 
Deretic. “But only if you didn’t know some-
thing else. And that is a fi  nding in yeast that 
autophagy is not only degradative, but can 
also serve in some biosynthetic pathways,” 
including the traffi  cking of the Cvt protein to 
the vacuole (5). Together, the results suggest 
that Gag may piggyback on autophagosomes 
or their components, perhaps for locomotive 
services, to complete its maturation.
The fi   ndings help explain a 2008 
functional genomics screen that linked 
autophagy  proteins with increased HIV 
replication (6). During normal HIV invasion 
in macrophages, Deretic’s group found, im-
mature autophagosomes accumulated. But 
late stages of maturation—those that create 
degradative organelles—did not occur.
The group then sought 
the viral agitator that blocks 
autophagosome maturation 
and allows Gag process-
ing. Their primary candidate 
was an HIV protein called 
Nef, which interacts with the 
vacuolar proton ATPase and, 
they thought, might thereby 
block acidifi  cation steps nec-
essary to make a degradative 
organelle. Using a mutant 
virus, the group showed that HIV lacking Nef 
no longer profi  ted from increased autophagy 
and was instead degraded.
It is not yet clear exactly how Nef 
blocks autophagosome maturation. The 
authors found the viral protein in complexes 
with autophagy regulatory proteins, includ-
ing a central regulator of the autophagosomal 
pathway called Beclin 1. A Nef mutation that 
interfered with its Beclin 1 interaction no lon-
ger led to increases in early autophagosomal 
markers. Beclin 1 is also hijacked by another 
viral protein—herpesvirus vBcl-2—but the 
herpesvirus blockade of autophagocytosis 
appears to happen at a much earlier stage (7).
Clinical applications, although tempt-
ing, may be far down the road. If the idea 
is to kill the virus using drugs such as 
rapamycin,  which induces autophagy, it 
will fi  rst be necessary to block Nef, notes 
Deretic. The idea is not without natural 
support. “There were cases in Australia 
involving HIV strains that lacked Nef,” he 
says. “And these people would not progress 
to AIDS, meaning the virus is disabled.”
Deretic has other exciting ideas. Highly 
active anti-retroviral therapy often does a 
smashing job clearing viral loads from the 
blood. But the pathogen can persist in 
particular locales such as gut lymphoid 
tissue (8). “My hope,” says Deretic, “is to go 
after these reservoirs and chew up the virus 
that for some reason is not readily accessible 
or susceptible to the anti-retroviral therapy. 
I have great hope that autophagy will help us 
with that. This is something we didn’t have on 
our radar screens just fi  ve years ago.”
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(L-R) George Kyei, Christina Dinkins, Vojo Deretic, and colleagues found that the HIV Gag protein 
(green) localized to autophagosomes (red). Another HIV protein, Nef, blocks the later stages of 
autophagosome maturation to allow full Gag processing and increase viral yield.
“My hope is 
to chew up the 
virus that  is 
not readily 
accessible to the 
anti-retroviral 
therapy.”
Virus avoids degradation and turns pathway into a helping hand for 
virion production.
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